Market Update: REGN
Regeneron Roars into the New Year: What’s Behind the Biotech Giant’s Market Surge? The market for Regeneron Pharmaceuticals (REGN) has been nothing short of electric in recent months, with shares showcasing a significant surge that has outpaced much of the industry. The biotech giant, headquartered in Tarrytown, New York, has been driven by a flurry…